EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Calcitonin Receptor is a Novel Biomarker for NF-κB-Mediated Cellular Stress in Triple-Negative Breast Cancer Cells

Hanieh Heydarlou, Reza Maleki, Peter J Wookey, Eric Smith, Wendy V Ingman

Frontiers in Bioscience-Landmark · 2026-04-24 · 31 (4)

DOI: 10.31083/fbl50148 ↗

At a glance

Journal article in Frontiers in Bioscience-Landmark, published online on 2026-04-24. Written by Hanieh Heydarlou and 4 co-authors. Institution: School of Medicine, College of Health, Adelaide University, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. Major MEDLINE topics: Triple Negative Breast Neoplasms, NF-kappa B, Receptors, Calcitonin, Biomarkers, Tumor. Cited 1 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research Council of Australia, Australian Government Research Training Program (RTP) Scholarship, Supplementary scholarships from The Hospital Research Foundation Group.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Cellular stress can arise from external and internal stimuli and induce mechanisms that either maintain survival or activate cell death pathways. Nuclear factor kappa B (NF-κB) is a key transcription factor that mediates a range of responses to cellular stress, including senescence, DNA repair, and inflammation in breast cancer; however, there are currently limited biomarkers that identify its activation. CalRexinTM, a monoclonal antibody that targets the human calcitonin receptor, was investigated as a novel biomarker for cell stress associated with NF-κB activation.

Methods

Triple-negative breast cancer cell lines MDA-MB-231 and MDA-MB-468 were treated with lipopolysaccharide (LPS) to induce NF-κB-mediated cellular stress or treated with the cytotoxin staurosporine to induce apoptosis as a positive control. CalRexinTM and Annexin V positivity were investigated by flow cytometry and immunofluorescence.

Results

Flow cytometry analysis revealed a dose- and time-dependent increase in the mean fluorescence intensity of CalRexinTM following LPS treatment of breast cancer cells. The mean fluorescence intensity of Annexin V, as a marker of apoptosis was not increased by LPS treatment and the cells remained viable. Immunofluorescence imaging demonstrated CalRexinTM positivity in LPS-stimulated cells accompanied by nuclear translocation of NF-κB.

Conclusion

Increased expression of calcitonin receptor, identified using the novel CalRexinTM antibody, has potential use as a biomarker for NF-κB-mediated cellular stress in breast cancer cells.

Subjects

MeSH terms (MEDLINE)

Triple Negative Breast NeoplasmsNF-kappa BReceptors, CalcitoninBiomarkers, TumorStress, PhysiologicalHumansFemaleApoptosisCell Line, TumorMDA-MB-231 CellsLipopolysaccharides

Author keywords

NF-κBapoptosiscalcitonin receptorcell survivalstresstriple negative breast cancer

Substances

NF-kappa BReceptors, CalcitoninBiomarkers, TumorLipopolysaccharides

Authors and institutions

  • School of Medicine, College of Health, Adelaide University, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia.
  • Robinson Research Institute, Adelaide University, Adelaide, SA 5005, Australia.
  • Department of Medicine-Austin, University of Melbourne, Austin Health, Heidelberg, VIC 3084, Australia.
  • Medical Oncology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia.

Funding

  • National Health and Medical Research Council of Australia
  • Australian Government Research Training Program (RTP) Scholarship
  • Supplementary scholarships from The Hospital Research Foundation Group

Cite

APA

Heydarlou, H., Maleki, R., Wookey, P. J., Smith, E., & Ingman, W. V. (2026). Calcitonin Receptor is a Novel Biomarker for NF-κB-Mediated Cellular Stress in Triple-Negative Breast Cancer Cells. Frontiers in Bioscience-Landmark, 31(4). https://doi.org/10.31083/fbl50148

Vancouver

Heydarlou H, Maleki R, Wookey PJ, Smith E, Ingman WV. Calcitonin Receptor is a Novel Biomarker for NF-κB-Mediated Cellular Stress in Triple-Negative Breast Cancer Cells. Frontiers in Bioscience-Landmark. 2026;31(4). doi:10.31083/fbl50148

BibTeX
@article{Heydarlou2026,
  author = {Heydarlou, Hanieh and Maleki, Reza and Wookey, Peter J and Smith, Eric and Ingman, Wendy V},
  title = {Calcitonin Receptor is a Novel Biomarker for NF-κB-Mediated Cellular Stress in Triple-Negative Breast Cancer Cells},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {4},
  doi = {10.31083/fbl50148}
}
Start for free →